Evogene Ltd.
EVGNNasdaq
$0.63
↑ +7.6%Jul 17 close · end-of-day
Price
1Y↓ -49.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Evogene Ltd. focuses on product discovery and development in multiple life-science based industries, including human health and agriculture. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer.
- CEO
- Ofer Haviv
- Sector
- Manufacturing
- Industry
- Chemicals
- Employees
- 140
- Website
- evogene.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 9, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.